Topline results were announced from a phase 3 trial evaluating the safety, tolerability, and immunogenicity of Pfizer-BioNTech’s LP.8.1-adapted COVID-19 vaccine.

Semaglutide was associated with a significantly greater reduction in MACE risk vs tirzepatide in patients with overweight/obesity and CVD.

For patients with acute myocardial infarction (MI), beta-blockers are not beneficial in those without reduced left ventricular ejection fraction (LVEF).

Reducing thrombolysis-to-puncture time improves outcomes in patients with AIS caused by LVO receiving IVT followed by EVT.

Vonvendi is a recombinant von Willebrand factor previously only approved for on-demand and perioperative use in adults with VWD and routine prophylactic use in adults with severe Type 3 VWD receiving ...

Topline data were announced from a trial evaluating enlicitide in adults with hypercholesterolemia on a moderate or high intensity statin.

For patients with inflammatory bowel disease and obesity, bariatric surgery is associated with improved inflammatory bowel disease-related outcomes.

For women with myocardial infarction (MI), beta-blocker therapy is associated with worse outcomes, according to a study published online.

Multimodal AOMs were associated with the highest preoperative weight loss among patients with high BMI undergoing bariatric surgery.

Adults with obesity prefer a primary care visit characterized by respectful treatment and listening, according to a study published online.

In patients with in-hospital silent graft occlusion after CABG, there is increased risk for angina-related rehospitalization and revascularization.

Oral spironolactone 25 mg daily does not improve CV mortality or hospitalization risk related to HF among patients with kidney failure receiving dialysis.